Skip to main content
Premium Trial:

Request an Annual Quote

Keygene Adds Second 454 Sequencer for Plant Genome Jobs

NEW YORK (GenomeWeb News) – Keygene said today that it has added a second 454 GS FLX sequencer from Roche to its arsenal, and it has upgraded both sequencers to the higher-throughput Titanium systems for use in the company’s headquarters in the Netherlands.
The company said it will use its enhanced sequencing power to meet increasing demand for whole genome crop plant projects. The company also said it has made “new investments” in its bioinformatics infrastructure to handle large-scale data storage and analysis projects such as mining SNPs, mutant alleles, gene identification, and genome assembly.
Keygene will use identified SNPs for “cost effective genotyping and molecular breeding of field, vegetable, and flower crops,” the firm said.
Keygene’s VP of Business Development, Mark van Haaren, said in a statement that its past sequencing and informatics enhancements have allowed the company to “develop new applications such as a novel whole genome sequencing procedure of smaller to mid-sized plant genomes.” 
The company bought its first GS FLX in April 2007.
Financial terms of the agreement were not released.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.